Cast21

Cast21 develops innovative orthopedic solutions, focusing on advanced immobilization products that enhance recovery for active patients. Their offerings are designed for comfort, mobility, and efficiency in treatment. Cast21, founded in 2015 in Memphis, US, specializes in advanced orthopedic immobilization solutions. The company was established by individuals passionate about improving patient care in orthopedics.

Ashley Moy leads the company as CEO. In January 2017, Cast21 secured USD 0. 8 mn in Seed funding from numerous investors including Bindley Capital Partners and Illinois Ventures, contributing to its total amount raised of USD 0. 8 mn.

The company has completed two deals to date. Cast21 specializes in innovative orthopedic solutions through advanced immobilization nets tailored for active patients. Their core product, waterproof and breathable braces, allows quick application in just three minutes, addressing the limitations of traditional casting methods. The company caters to a diverse clientele including pediatric, adult, and geriatric patients, as well as athletes across various international markets, enhancing orthopedic and sports medical care.

Cast21 generates revenue through direct sales of its patented orthopedic immobilization products to healthcare providers, clinics, and hospitals. Utilizing a B2B model, the company establishes partnerships with medical facilities that require its innovative solutions for patient care. Transaction structures include bulk purchasing agreements for supplies, supplemented by customizable options that enhance patient recovery. Following the Seed funding round in January 2017, Cast21 aims to expand its product line with new orthopedic solutions designed to further improve patient mobility and comfort.

The company is exploring opportunities to enter new markets, particularly targeting regions with high demand for advanced medical solutions. The recent funding will support the development of these initiatives and facilitate market expansion efforts.